Difference between revisions of "Process Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
Line 23: Line 23:
 
::* Then we need to ensure that the QIBA Templates/Process supports those things clearly.
 
::* Then we need to ensure that the QIBA Templates/Process supports those things clearly.
 
::* Kevin will put some initial thoughts on a Wiki page and we can review/add
 
::* Kevin will put some initial thoughts on a Wiki page and we can review/add
 +
::* How often should conformance assessment be done, who will assess, who will keep records?
 
::* Should QIBA get into hosting the Conformance Statements on our site (and then we could link to them from the Profiles page which would be very handy)
 
::* Should QIBA get into hosting the Conformance Statements on our site (and then we could link to them from the Profiles page which would be very handy)
 
::* Consider the RSNA Image Share Conformance Assessment Program and whether we should do something similar for QIBA  
 
::* Consider the RSNA Image Share Conformance Assessment Program and whether we should do something similar for QIBA  
Line 34: Line 35:
 
::* Embed the checklist as an appendix
 
::* Embed the checklist as an appendix
  
:* Claim Guidance
+
:* ?Statistical Testing Guidance?
::* '''Committee will review the current doc (see below) and post to the wiki'''
+
::*  
::* Next revision cycle (2017Q3?)
+
::* Symmetrical vs Assymetrical change intervals?
:::* Try to include a greater variety of modalities/targets.
+
::* Questions about the numbers in "Academic Radiology: ?? Paper"
:::* See if we have come across a good example for TDI based CI (e.g. Scenarios BDFMNO)
 
:::* PDFF will bring in a new style with a bias and slope that isn't 1.
 
:::* MRE also different. Getting absolute measure not relative? Longitudinal claim. Assuming linearity based on some data, but not assessing yet.
 
  
:* Profile Disclaimer
+
:* Clinical Confirmation Process
::* '''Consult RSNA about what disclaimer should address''' (need soon since we're starting to promote/distribute Profiles)
+
::* Methodology/Study Design guidance/requirements for achieving "Clinically Confirmed"
::* Draft standardized disclaimer text for profiles
 
  
 
:* Committee Operations
 
:* Committee Operations
Line 50: Line 47:
 
::* Add as standing agenda item on the Coordinating Cmte call to check with their Biomarker Cmte chairs
 
::* Add as standing agenda item on the Coordinating Cmte call to check with their Biomarker Cmte chairs
 
::* Sketch a Sunset procedure for retiring Task Forces and Biomarker Committees that have completed their work.
 
::* Sketch a Sunset procedure for retiring Task Forces and Biomarker Committees that have completed their work.
::* Document some guidance for selecting leadership of various QIBA committees (different stakeholders, expected duties?)
 
 
::* Propose policy/process to consider Prior Project completion when Steering Cmte reviews new Proposals from the same PI.
 
::* Propose policy/process to consider Prior Project completion when Steering Cmte reviews new Proposals from the same PI.
 
:::* timing overlap of prior cycle completion period with new proposal period needs to be one considered.
 
:::* timing overlap of prior cycle completion period with new proposal period needs to be one considered.
Line 57: Line 53:
 
:* QIBA Wiki
 
:* QIBA Wiki
 
::* [[QIBA Wiki Improvements]]
 
::* [[QIBA Wiki Improvements]]
 
+
::* Consider how to handle handoffs between RSNA website
 +
::* Wiki serves QIBA Committee work. Consider a new user oriented site (clinicians, administrators).
 +
:::* '''Maybe a new TF to support Adoption (can include some Process people)'''
 +
:::* Ed, Brad, Joe, Kevin, Dan, RSNA Webperson
 +
::::* Start by looking at what is on the RSNA QIBA pages,
  
 
:* Literature Search
 
:* Literature Search
 +
::* '''Ask for a status update?'''
 
::* Process/best practices for initial literature search around a new biomarker/profile
 
::* Process/best practices for initial literature search around a new biomarker/profile
 
::* Does someone have a draft set of guidance to kick this off? (Nancy, Anna Wu, Hendrik Lau, Andy)
 
::* Does someone have a draft set of guidance to kick this off? (Nancy, Anna Wu, Hendrik Lau, Andy)
 
::* Where do you store references, what kind of search works best, what exactly are you looking for?
 
::* Where do you store references, what kind of search works best, what exactly are you looking for?
 
::* Also meta-analysis guidance to determine sources and levels of variance
 
::* Also meta-analysis guidance to determine sources and levels of variance
 +
::* PDF/DWI - using Google Sheet to track/tabulate/organize - inherently input from many sources so nice to have centralized, commonly edited, accessible
  
 
:* Profile Selection Process
 
:* Profile Selection Process
Line 84: Line 86:
 
::* Address relationship between wiki content (current, easy to update) and website content (authoritative, stable)
 
::* Address relationship between wiki content (current, easy to update) and website content (authoritative, stable)
 
:::* Likely RSNA staff will periodically mirror wiki content up onto the website; address this in publication process.
 
:::* Likely RSNA staff will periodically mirror wiki content up onto the website; address this in publication process.
 
:* Clinical Confirmation Process
 
::* Methodology/Study Design guidance/requirements for achieving "Clinically Confirmed"
 
  
 
:* On-boarding process
 
:* On-boarding process
Line 100: Line 99:
 
:* Guidelines for assessment procedures to vet SW in Profiles
 
:* Guidelines for assessment procedures to vet SW in Profiles
 
:* Clarify QIBA Profile vs UPICT Protocol (Venn Diagram)
 
:* Clarify QIBA Profile vs UPICT Protocol (Venn Diagram)
 +
 +
:* Claim Guidance
 +
::* Next revision cycle (2017Q3?)
 +
:::* Try to include a greater variety of modalities/targets.
 +
:::* See if we have come across a good example for TDI based CI (e.g. Scenarios BDFMNO)
 +
:::* PDFF will bring in a new style with a bias and slope that isn't 1.
 +
:::* MRE also different. Getting absolute measure not relative? Longitudinal claim. Assuming linearity based on some data, but not assessing yet.
 +
 +
:* Profile Disclaimer
 +
::* Revist if Discriminatory Claims are addressed.
 +
::* Consult RSNA about what disclaimer should address
 +
::* Draft standardized disclaimer text for profiles
 +
::* If QIBA did Discriminatory Claims, then there would be a stronger need for disclaimer, but lacking clinical outcome statments, maybe we don't have as strong a need?  We stick to technical performance.
  
 
==Working Documents==
 
==Working Documents==

Revision as of 21:54, 22 February 2017

Chairs: Kevin O'Donnell (Chair); Dan Sullivan, MD (Vice-chair)
Secretary: Susan Weinmann (RSNA Staff)
Roster: <link to roster of active attendees and who has voting privileges>

Scope

The Process Committee facilitates the QIBA Coordinating Committees and their profiling activities by defining processes and tools to promote consistent quality work product.

  • Develop common Templates & Processes
  • Support & mentor adoption of above
  • Drive consistent content & format of Profiles
  • Support infrastructure for Committees

Meetings

Current Work

  • Conformance Process
  • What should go into a Conformance Record? - (e.g. findings from Tech Conf tests)
  • Need a common view of what conformance entails, how it is achieved, what it looks like to a product, how it is documented, etc.
  • Then we need to ensure that the QIBA Templates/Process supports those things clearly.
  • Kevin will put some initial thoughts on a Wiki page and we can review/add
  • How often should conformance assessment be done, who will assess, who will keep records?
  • Should QIBA get into hosting the Conformance Statements on our site (and then we could link to them from the Profiles page which would be very handy)
  • Consider the RSNA Image Share Conformance Assessment Program and whether we should do something similar for QIBA
  • Process committee can think through the details of a process and confer with RSNA whether they would be interested
  • Profile Template
  • Adjust Profile Template (change tracked) to regroup time-muddled Activities
  • Conformance Section - connect the dots
  • Support adoption of the updated Profile Template.
  • Harmonize assessment procedures across profiles
  • Embed the checklist as an appendix
  • ?Statistical Testing Guidance?
  • Symmetrical vs Assymetrical change intervals?
  • Questions about the numbers in "Academic Radiology: ?? Paper"
  • Clinical Confirmation Process
  • Methodology/Study Design guidance/requirements for achieving "Clinically Confirmed"
  • Committee Operations
  • Coordinating Cmtes need to remind/confirm BC committees keep their page up to date (especially links to current draft documents)
  • Add as standing agenda item on the Coordinating Cmte call to check with their Biomarker Cmte chairs
  • Sketch a Sunset procedure for retiring Task Forces and Biomarker Committees that have completed their work.
  • Propose policy/process to consider Prior Project completion when Steering Cmte reviews new Proposals from the same PI.
  • timing overlap of prior cycle completion period with new proposal period needs to be one considered.
  • possible solution would require final reports for prior COMPLETED funding cycles before considering a new project proposal
  • QIBA Wiki
  • QIBA Wiki Improvements
  • Consider how to handle handoffs between RSNA website
  • Wiki serves QIBA Committee work. Consider a new user oriented site (clinicians, administrators).
  • Maybe a new TF to support Adoption (can include some Process people)
  • Ed, Brad, Joe, Kevin, Dan, RSNA Webperson
  • Start by looking at what is on the RSNA QIBA pages,
  • Literature Search
  • Ask for a status update?
  • Process/best practices for initial literature search around a new biomarker/profile
  • Does someone have a draft set of guidance to kick this off? (Nancy, Anna Wu, Hendrik Lau, Andy)
  • Where do you store references, what kind of search works best, what exactly are you looking for?
  • Also meta-analysis guidance to determine sources and levels of variance
  • PDF/DWI - using Google Sheet to track/tabulate/organize - inherently input from many sources so nice to have centralized, commonly edited, accessible
  • Profile Selection Process
  • Consider additional criteria/evaluation based on experiences
  • Profile Maintenance Process
  • Propose change tracking process
  • Propose conventions for Profile editions/versions
  • Profile Retirement Process
  • Publication Process
  • Sketch up publication process for Official Docs (CC approval vote, send to RSNA Staff)
  • Write up Standard Approval Practices for committee documents
  • Quality check mechanism, voting mechanism
  • Start simple with this and add complexity only as needed.
  • Address relationship between wiki content (current, easy to update) and website content (authoritative, stable)
  • Likely RSNA staff will periodically mirror wiki content up onto the website; address this in publication process.
  • On-boarding process
  • Help new committees, new members, new authors, new reviewers, new adopters
  • Add some "readers guide" text for reviewers, e.g. focus on Spec tables. Look at your relevant Activities/Procedures. Read the Discussion sections for more background.
  • "How to develop a Profile" Guidance
  • Joe's intro email, current template and stage docs, QIBA Fact Sheet
  • Could use a "fresh eyes"/newcomer commentary
  • Dan will send the current Fact Sheet to UCSF for feedback on contents
  • Kevin will work with Joe to get it into a Google Doc for revision and linking from the Wiki.
  • Guidelines for Reference Implementations and commercial products in Profiles (underlying algorithm available, list all comers, non-commercial?, etc).
  • Guidelines for assessment procedures to vet SW in Profiles
  • Clarify QIBA Profile vs UPICT Protocol (Venn Diagram)
  • Claim Guidance
  • Next revision cycle (2017Q3?)
  • Try to include a greater variety of modalities/targets.
  • See if we have come across a good example for TDI based CI (e.g. Scenarios BDFMNO)
  • PDFF will bring in a new style with a bias and slope that isn't 1.
  • MRE also different. Getting absolute measure not relative? Longitudinal claim. Assuming linearity based on some data, but not assessing yet.
  • Profile Disclaimer
  • Revist if Discriminatory Claims are addressed.
  • Consult RSNA about what disclaimer should address
  • Draft standardized disclaimer text for profiles
  • If QIBA did Discriminatory Claims, then there would be a stronger need for disclaimer, but lacking clinical outcome statments, maybe we don't have as strong a need? We stick to technical performance.

Working Documents

Claim Guidance

Profile Stages

Wiki Layout

See Also

This page is based on the Committee Template. Add any good ideas you have to the template.